Founded in 2021, Isomorphic Labs is a subsidiary of Google parent Alphabet. It is currently preparing to dose the first patients with the AI-engineered drug in clinical trials and is “staffing up” ...

Google DeepMind CEO Demis Hassabis has said that AI can have a serious crack at solving all diseases in the coming years. And ...

After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials. Isomorphic Labs, the ...

Microsoft has added preview support for the Model Context Protocol (MCP) to its Azure AI Foundry Agent Service, aiming for ...

Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.

Alphabet's AI drug development subsidiary Isomorphic Labs is aiming to initiate clinical trials for its AI-developed oncology drugs. In an interview with Fortune, Isomorphic Labs president Colin ...

Google's Veo 3 AI video generator is now available globally for AI Pro subscribers, a key move in its revamped two-tier ...

There's little unexpected about this, especially as Genie 2, an AI model capable of generating interactive 3D environments, ...

Demis Hassabis, CEO of Google DeepMind, hinted Tuesday evening that Veo 3, Google’s latest video generating model, could ...

Demis Hassabis, CEO of Google’s DeepMind, teased a potentially groundbreaking direction for Google’s latest video-generating AI model, Veo 3, hinting it could someday power interactive video game ...

For the first of these tasks Dr Baker and his colleagues use RF diffusion, an AI model they have developed to predict a ...

Beware the tech leaders making grandiose statements about artificial intelligence. They have lost sight of reality, says ...